Q: The tie-up with Tabula Rasa and their DosemeRx platform was considered to be a potential game changer for Physiomics. Now that Tabula Rasa have advised the market that they are selling their interest in DosemeRx does this in any way diminish this commercial potential The answer to this was also covered during the main presentation however just to say that DoseMeRx remains interested in working...
Read More